| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.46e-06 | 18 | 96 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 9.40e-06 | 28 | 96 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.93e-05 | 37 | 96 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | actin binding | 1.03e-04 | 479 | 96 | 10 | GO:0003779 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.27e-04 | 5 | 96 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.64e-04 | 118 | 96 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 2.90e-04 | 27 | 96 | 3 | GO:0004112 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.61e-04 | 70 | 96 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH8 IQGAP2 SYNE1 SPTBN2 YWHAH IQGAP1 GOLGA8N DST SYNE2 CLTC MACF1 RP1 GOLGA8O UTRN | 7.54e-04 | 1099 | 96 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | 7.99e-04 | 227 | 96 | 6 | GO:0051015 | |
| GeneOntologyBiologicalProcess | Golgi organization | DYNC2H1 COG7 SYNE1 GOLGA8R GOLGA8Q GOLGA8N AKAP9 HACE1 CLTC GOLGA8O | 6.06e-09 | 168 | 96 | 10 | GO:0007030 |
| GeneOntologyBiologicalProcess | organelle assembly | CCP110 DYNC2H1 SYNE1 SPTBN2 BBS9 GOLGA8N DNAAF8 MTOR SYNE2 HGS CLTC TTC21B RP1 ATM GOLGA8O DNAH5 DNAH8 DYNC1H1 KNL1 | 1.04e-06 | 1138 | 96 | 19 | GO:0070925 |
| GeneOntologyBiologicalProcess | endomembrane system organization | DYNC2H1 COG7 ESYT1 SYNE1 GOLGA8R GOLGA8Q GOLGA8N AKAP9 HGS HACE1 CLTC GOLGA8O KNL1 | 1.40e-05 | 672 | 96 | 13 | GO:0010256 |
| GeneOntologyBiologicalProcess | response to radiation | SYNE1 COP1 CASP9 SEMA5A INTS3 GPR179 MTOR RP1 ATM SPIDR TP53BP1 | 2.21e-05 | 503 | 96 | 11 | GO:0009314 |
| GeneOntologyBiologicalProcess | microtubule-based process | CCP110 DYNC2H1 GOLGA8N DNAAF8 DST AKAP9 SYNE2 CLTC TTC21B MACF1 RP1 GOLGA8O PPP2R3C DNAH5 DNAH8 DYNC1H1 | 2.83e-05 | 1058 | 96 | 16 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CCP110 GOLGA8N DNAAF8 DST AKAP9 SYNE2 CLTC RP1 GOLGA8O PPP2R3C DNAH5 DNAH8 DYNC1H1 | 2.87e-05 | 720 | 96 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | NES IQGAP2 CTC1 INTS3 YWHAH IQGAP1 GOLGA8N DBF4 ANAPC2 CLTC ATM GOLGA8O DYNC1H1 KNL1 | 3.99e-05 | 854 | 96 | 14 | GO:1903047 |
| GeneOntologyBiologicalProcess | cilium assembly | CCP110 DYNC2H1 SYNE1 BBS9 DNAAF8 SYNE2 TTC21B RP1 DNAH5 DNAH8 | 4.18e-05 | 444 | 96 | 10 | GO:0060271 |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 4.93e-05 | 280 | 96 | 8 | GO:1902115 | |
| GeneOntologyBiologicalProcess | nucleus localization | 5.19e-05 | 44 | 96 | 4 | GO:0051647 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 6.41e-05 | 3 | 96 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 6.41e-05 | 3 | 96 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 6.41e-05 | 3 | 96 | 2 | GO:1902407 | |
| GeneOntologyBiologicalProcess | cilium organization | CCP110 DYNC2H1 SYNE1 BBS9 DNAAF8 SYNE2 TTC21B RP1 DNAH5 DNAH8 | 7.47e-05 | 476 | 96 | 10 | GO:0044782 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | NES RAPH1 SYNE1 ETV1 SEMA5A YWHAH IQGAP1 GOLGA8N DST ANAPC2 KNDC1 MACF1 GOLGA8O | 1.16e-04 | 826 | 96 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 1.28e-04 | 4 | 96 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | CCP110 NES IQGAP2 CTC1 SYNE1 SPTBN2 SEMA5A YWHAH AKAP9 MTOR SYNE2 ANAPC2 CLTC RP1 ATM DYNC1H1 KNL1 | 1.40e-04 | 1342 | 96 | 17 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | CCP110 SYNE1 SEMA5A YWHAH IQGAP1 GOLGA8N MTOR SYNE2 ANAPC2 KNDC1 MACF1 RP1 GOLGA8O | 1.47e-04 | 846 | 96 | 13 | GO:0120035 |
| GeneOntologyBiologicalProcess | protein localization to organelle | CACNA2D2 DYNC2H1 COG7 SYNE1 GNPTG BBS9 MTOR HGS TTC21B MACF1 TIMM29 SPIDR HSPA1L TP53BP1 KNL1 | 1.50e-04 | 1091 | 96 | 15 | GO:0033365 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | CCP110 SYNE1 SEMA5A YWHAH IQGAP1 GOLGA8N MTOR SYNE2 ANAPC2 KNDC1 MACF1 RP1 GOLGA8O | 1.79e-04 | 863 | 96 | 13 | GO:0031344 |
| GeneOntologyBiologicalProcess | outer dynein arm assembly | 1.84e-04 | 24 | 96 | 3 | GO:0036158 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.93e-04 | 114 | 96 | 5 | GO:0050772 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | NES IQGAP2 CTC1 INTS3 YWHAH IQGAP1 GOLGA8N DBF4 ANAPC2 CLTC ATM GOLGA8O DYNC1H1 KNL1 | 2.44e-04 | 1014 | 96 | 14 | GO:0000278 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | CCP110 DYNC2H1 SYNE1 BBS9 DNAAF8 MTOR SYNE2 TTC21B RP1 DNAH5 DNAH8 | 2.82e-04 | 670 | 96 | 11 | GO:0120031 |
| GeneOntologyBiologicalProcess | developmental growth | PDE4D RAPH1 CACNA2D2 CTC1 SPTBN2 RDH10 SEMA5A IQGAP1 MTOR CTR9 ANAPC2 MACF1 ATM | 3.03e-04 | 911 | 96 | 13 | GO:0048589 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 3.21e-04 | 278 | 96 | 7 | GO:0031503 | |
| GeneOntologyBiologicalProcess | cell projection assembly | CCP110 DYNC2H1 SYNE1 BBS9 DNAAF8 MTOR SYNE2 TTC21B RP1 DNAH5 DNAH8 | 3.40e-04 | 685 | 96 | 11 | GO:0030031 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | RAPH1 SYNE1 ETV1 SEMA5A YWHAH IQGAP1 GOLGA8N DST ANAPC2 KNDC1 MACF1 GOLGA8O | 3.43e-04 | 802 | 96 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | 3.79e-04 | 582 | 96 | 10 | GO:0044089 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | CCP110 SYNE1 SPTBN2 FAF1 IQGAP1 PTPN13 AKAP9 MTOR SYNE2 HGS MACF1 RP1 ATM SPIDR DYNC1H1 | 3.79e-04 | 1189 | 96 | 15 | GO:0044087 |
| GeneOntologyBiologicalProcess | cell morphogenesis | NES ZNF135 RAPH1 SYNE1 ETV1 CASP9 SEMA5A YWHAH IQGAP1 GOLGA8N DST ANAPC2 KNDC1 MACF1 GOLGA8O | 3.96e-04 | 1194 | 96 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | RAPH1 SYNE1 ETV1 SEMA5A YWHAH IQGAP1 GOLGA8N DST ANAPC2 KNDC1 MACF1 GOLGA8O | 4.15e-04 | 819 | 96 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | organelle localization | ESYT1 SYNE1 GOLGA8N AKAP9 MTOR SYNE2 HGS ATM GOLGA8O DYNC1H1 KNL1 | 4.23e-04 | 703 | 96 | 11 | GO:0051640 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 4.94e-04 | 494 | 96 | 9 | GO:0031346 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 5.27e-04 | 34 | 96 | 3 | GO:0008356 | |
| GeneOntologyBiologicalProcess | nuclear migration | 5.27e-04 | 34 | 96 | 3 | GO:0007097 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | CCP110 NES SYNE1 SEMA5A FAF1 IQGAP1 GOLGA8N AKAP9 MTOR ANAPC2 MACF1 RP1 ATM SPIDR GOLGA8O DYNC1H1 | 5.39e-04 | 1366 | 96 | 16 | GO:0051130 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | SYNE1 SEMA5A YWHAH IQGAP1 GOLGA8N MTOR ANAPC2 KNDC1 MACF1 GOLGA8O | 5.61e-04 | 612 | 96 | 10 | GO:0010975 |
| GeneOntologyBiologicalProcess | protein depolymerization | 5.68e-04 | 144 | 96 | 5 | GO:0051261 | |
| GeneOntologyBiologicalProcess | centrosome localization | 5.74e-04 | 35 | 96 | 3 | GO:0051642 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA2D2 SYNE1 SPTBN2 ETV5 YWHAG YWHAH AKAP9 MTOR ANAPC2 CLMP HTR3B GRIN3A UTRN | 5.82e-04 | 976 | 96 | 13 | GO:0099536 |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 6.24e-04 | 36 | 96 | 3 | GO:0061842 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 6.83e-04 | 150 | 96 | 5 | GO:0050773 | |
| GeneOntologyBiologicalProcess | response to ionizing radiation | 7.04e-04 | 151 | 96 | 5 | GO:0010212 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | RAPH1 SYNE1 ETV1 SEMA5A YWHAH GOLGA8N DST ANAPC2 KNDC1 MACF1 GOLGA8O | 7.09e-04 | 748 | 96 | 11 | GO:0048667 |
| GeneOntologyBiologicalProcess | visual perception | 7.24e-04 | 230 | 96 | 6 | GO:0007601 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 7.56e-04 | 9 | 96 | 2 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 7.56e-04 | 9 | 96 | 2 | GO:0000912 | |
| GeneOntologyBiologicalProcess | cAMP catabolic process | 7.56e-04 | 9 | 96 | 2 | GO:0006198 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 7.75e-04 | 233 | 96 | 6 | GO:0050953 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 8.64e-04 | 158 | 96 | 5 | GO:0030177 | |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 9.16e-04 | 41 | 96 | 3 | GO:0070286 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring organization | 9.42e-04 | 10 | 96 | 2 | GO:0044837 | |
| GeneOntologyBiologicalProcess | cell cycle process | CCP110 NES IQGAP2 CTC1 INTS3 YWHAH IQGAP1 GOLGA8N DBF4 ANAPC2 CLTC ATM GOLGA8O DYNC1H1 TP53BP1 KNL1 | 9.58e-04 | 1441 | 96 | 16 | GO:0022402 |
| GeneOntologyBiologicalProcess | dendrite development | 9.70e-04 | 335 | 96 | 7 | GO:0016358 | |
| GeneOntologyCellularComponent | microtubule | IQGAP2 DYNC2H1 IQGAP1 GOLGA8N DST CLTC MACF1 CLMP RP1 GOLGA8O DNAH5 DNAH8 DYNC1H1 | 1.24e-06 | 533 | 98 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | supramolecular fiber | NES MYH8 PDE4D IQGAP2 DYNC2H1 SYNE1 IQGAP1 GOLGA8N DST SYNE2 CLTC MACF1 CLMP RP1 LUM GOLGA8O DNAH5 DNAH8 DYNC1H1 | 2.00e-06 | 1179 | 98 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | NES MYH8 PDE4D IQGAP2 DYNC2H1 SYNE1 IQGAP1 GOLGA8N DST SYNE2 CLTC MACF1 CLMP RP1 LUM GOLGA8O DNAH5 DNAH8 DYNC1H1 | 2.21e-06 | 1187 | 98 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | Golgi cis cisterna | 1.67e-05 | 33 | 98 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | cis-Golgi network | 4.98e-05 | 85 | 98 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | NES IQGAP2 DYNC2H1 IQGAP1 GOLGA8N DST CLTC MACF1 CLMP RP1 GOLGA8O DNAH5 DNAH8 DYNC1H1 | 7.57e-05 | 899 | 98 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 8.06e-05 | 94 | 98 | 5 | GO:0032580 | |
| GeneOntologyCellularComponent | dynein complex | 1.20e-04 | 54 | 98 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | Golgi stack | 1.55e-04 | 171 | 98 | 6 | GO:0005795 | |
| GeneOntologyCellularComponent | triglyceride-rich plasma lipoprotein particle | 1.88e-04 | 24 | 98 | 3 | GO:0034385 | |
| GeneOntologyCellularComponent | very-low-density lipoprotein particle | 1.88e-04 | 24 | 98 | 3 | GO:0034361 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 2.36e-04 | 443 | 98 | 9 | GO:0098791 | |
| GeneOntologyCellularComponent | postsynapse | SYNE1 SPTBN2 SH2D5 GPR179 DST AKAP9 MTOR CLTC MACF1 CLMP HTR3B GRIN3A USP48 UTRN | 2.77e-04 | 1018 | 98 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | filopodium | 2.85e-04 | 123 | 98 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA2D2 SYNE1 GPR179 AKAP9 CLTC CLMP HTR3B GRIN3A USP48 UTRN | 4.09e-04 | 583 | 98 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | Golgi cisterna | 4.38e-04 | 135 | 98 | 5 | GO:0031985 | |
| GeneOntologyCellularComponent | high-density lipoprotein particle | 5.86e-04 | 35 | 98 | 3 | GO:0034364 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 6.38e-04 | 405 | 98 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | microtubule associated complex | 9.72e-04 | 161 | 98 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | lipoprotein particle | 1.15e-03 | 44 | 98 | 3 | GO:1990777 | |
| GeneOntologyCellularComponent | plasma lipoprotein particle | 1.15e-03 | 44 | 98 | 3 | GO:0034358 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.16e-03 | 11 | 98 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.16e-03 | 11 | 98 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.16e-03 | 11 | 98 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.16e-03 | 11 | 98 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.39e-03 | 12 | 98 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | protein-lipid complex | 1.40e-03 | 47 | 98 | 3 | GO:0032994 | |
| GeneOntologyCellularComponent | ciliary tip | 1.48e-03 | 48 | 98 | 3 | GO:0097542 | |
| MousePheno | abnormal dorsal spinal root morphology | 1.03e-05 | 8 | 81 | 3 | MP:0003994 | |
| MousePheno | abnormal locomotor coordination | CACNA2D2 ESYT1 SPTBN2 ETV1 LRRK1 STAT1 FAF1 GOLGA8N DST HGS ATM GOLGA8O DNAH5 DYNC1H1 TMEM63A | 1.54e-05 | 726 | 81 | 15 | MP:0003312 |
| MousePheno | abnormal neuromuscular synapse morphology | 1.81e-05 | 95 | 81 | 6 | MP:0001053 | |
| MousePheno | abnormal somatic motor system morphology | 2.16e-05 | 98 | 81 | 6 | MP:0001051 | |
| MousePheno | decreased pons size | 3.32e-05 | 2 | 81 | 2 | MP:0020533 | |
| MousePheno | abnormal synapse morphology | 4.52e-05 | 224 | 81 | 8 | MP:0009538 | |
| MousePheno | abnormal pons size | 9.91e-05 | 3 | 81 | 2 | MP:0020532 | |
| MousePheno | abnormal ventral spinal root morphology | 1.70e-04 | 19 | 81 | 3 | MP:0003993 | |
| MousePheno | abnormal gait | CACNA2D2 ESYT1 SPTBN2 LRRK1 STAT1 FAF1 DST ATM DNAH5 DYNC1H1 TMEM63A | 1.95e-04 | 520 | 81 | 11 | MP:0001406 |
| MousePheno | increased T cell derived lymphoma incidence | 2.47e-04 | 53 | 81 | 4 | MP:0002024 | |
| MousePheno | increased thymus tumor incidence | 2.65e-04 | 54 | 81 | 4 | MP:0010365 | |
| MousePheno | axonal dystrophy | 2.67e-04 | 22 | 81 | 3 | MP:0003225 | |
| Domain | CH | 1.56e-09 | 65 | 97 | 8 | SM00033 | |
| Domain | Actinin_actin-bd_CS | 1.58e-09 | 23 | 97 | 6 | IPR001589 | |
| Domain | Spectrin | 1.58e-09 | 23 | 97 | 6 | PF00435 | |
| Domain | ACTININ_2 | 1.58e-09 | 23 | 97 | 6 | PS00020 | |
| Domain | ACTININ_1 | 1.58e-09 | 23 | 97 | 6 | PS00019 | |
| Domain | CH | 2.86e-09 | 70 | 97 | 8 | PF00307 | |
| Domain | - | 3.21e-09 | 71 | 97 | 8 | 1.10.418.10 | |
| Domain | CH | 4.02e-09 | 73 | 97 | 8 | PS50021 | |
| Domain | CH-domain | 5.00e-09 | 75 | 97 | 8 | IPR001715 | |
| Domain | Spectrin_repeat | 7.24e-09 | 29 | 97 | 6 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.36e-08 | 32 | 97 | 6 | IPR018159 | |
| Domain | SPEC | 1.36e-08 | 32 | 97 | 6 | SM00150 | |
| Domain | DHC_N1 | 4.71e-08 | 8 | 97 | 4 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 4.71e-08 | 8 | 97 | 4 | IPR013594 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.58e-07 | 14 | 97 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.58e-07 | 14 | 97 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.58e-07 | 14 | 97 | 4 | IPR013602 | |
| Domain | DHC_N2 | 6.58e-07 | 14 | 97 | 4 | PF08393 | |
| Domain | MT | 6.58e-07 | 14 | 97 | 4 | PF12777 | |
| Domain | AAA_8 | 6.58e-07 | 14 | 97 | 4 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 6.58e-07 | 14 | 97 | 4 | IPR011704 | |
| Domain | AAA_5 | 6.58e-07 | 14 | 97 | 4 | PF07728 | |
| Domain | DHC_fam | 8.93e-07 | 15 | 97 | 4 | IPR026983 | |
| Domain | Dynein_heavy_dom | 8.93e-07 | 15 | 97 | 4 | IPR004273 | |
| Domain | Dynein_heavy | 8.93e-07 | 15 | 97 | 4 | PF03028 | |
| Domain | GOLGA2L5 | 1.98e-06 | 18 | 97 | 4 | PF15070 | |
| Domain | Golgin_A | 1.98e-06 | 18 | 97 | 4 | IPR024858 | |
| Domain | ApoL | 4.68e-06 | 7 | 97 | 3 | IPR008405 | |
| Domain | ApoL | 4.68e-06 | 7 | 97 | 3 | PF05461 | |
| Domain | RasGAP_C | 7.98e-05 | 3 | 97 | 2 | IPR000593 | |
| Domain | RasGAP_C | 7.98e-05 | 3 | 97 | 2 | PF03836 | |
| Domain | ETS_PEA3_N | 7.98e-05 | 3 | 97 | 2 | PF04621 | |
| Domain | ETS_PEA3_N | 7.98e-05 | 3 | 97 | 2 | IPR006715 | |
| Domain | KASH | 1.59e-04 | 4 | 97 | 2 | PF10541 | |
| Domain | KASH | 1.59e-04 | 4 | 97 | 2 | IPR012315 | |
| Domain | KASH | 1.59e-04 | 4 | 97 | 2 | PS51049 | |
| Domain | KASH | 1.59e-04 | 4 | 97 | 2 | SM01249 | |
| Domain | KIND_dom | 2.64e-04 | 5 | 97 | 2 | IPR011019 | |
| Domain | KIND | 2.64e-04 | 5 | 97 | 2 | SM00750 | |
| Domain | KIND | 2.64e-04 | 5 | 97 | 2 | PS51377 | |
| Domain | FATC | 2.64e-04 | 5 | 97 | 2 | PF02260 | |
| Domain | - | 3.95e-04 | 6 | 97 | 2 | 3.90.1290.10 | |
| Domain | FAT | 3.95e-04 | 6 | 97 | 2 | PS51189 | |
| Domain | FATC | 3.95e-04 | 6 | 97 | 2 | PS51190 | |
| Domain | FAT | 3.95e-04 | 6 | 97 | 2 | PF02259 | |
| Domain | GAR | 3.95e-04 | 6 | 97 | 2 | PS51460 | |
| Domain | PIK-rel_kinase_FAT | 3.95e-04 | 6 | 97 | 2 | IPR003151 | |
| Domain | FATC_dom | 3.95e-04 | 6 | 97 | 2 | IPR003152 | |
| Domain | - | 3.95e-04 | 6 | 97 | 2 | 3.30.920.20 | |
| Domain | PIK_FAT | 3.95e-04 | 6 | 97 | 2 | IPR014009 | |
| Domain | GAS_dom | 3.95e-04 | 6 | 97 | 2 | IPR003108 | |
| Domain | GAS2 | 3.95e-04 | 6 | 97 | 2 | PF02187 | |
| Domain | GAS2 | 3.95e-04 | 6 | 97 | 2 | SM00243 | |
| Domain | FATC | 3.95e-04 | 6 | 97 | 2 | SM01343 | |
| Domain | 14_3_3 | 5.51e-04 | 7 | 97 | 2 | SM00101 | |
| Domain | Plectin_repeat | 5.51e-04 | 7 | 97 | 2 | IPR001101 | |
| Domain | 1433_1 | 5.51e-04 | 7 | 97 | 2 | PS00796 | |
| Domain | 1433_2 | 5.51e-04 | 7 | 97 | 2 | PS00797 | |
| Domain | 14-3-3_domain | 5.51e-04 | 7 | 97 | 2 | IPR023410 | |
| Domain | 14-3-3_CS | 5.51e-04 | 7 | 97 | 2 | IPR023409 | |
| Domain | 14-3-3 | 5.51e-04 | 7 | 97 | 2 | PF00244 | |
| Domain | Plectin | 5.51e-04 | 7 | 97 | 2 | PF00681 | |
| Domain | PLEC | 5.51e-04 | 7 | 97 | 2 | SM00250 | |
| Domain | 14-3-3 | 7.32e-04 | 8 | 97 | 2 | IPR000308 | |
| Domain | RasGAP | 2.33e-03 | 14 | 97 | 2 | SM00323 | |
| Domain | RasGAP_CS | 2.33e-03 | 14 | 97 | 2 | IPR023152 | |
| Domain | WW_DOMAIN_2 | 2.36e-03 | 51 | 97 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 2.36e-03 | 51 | 97 | 3 | PS01159 | |
| Domain | WW_dom | 2.50e-03 | 52 | 97 | 3 | IPR001202 | |
| Domain | RasGAP | 2.68e-03 | 15 | 97 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 2.68e-03 | 15 | 97 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 2.68e-03 | 15 | 97 | 2 | PS50018 | |
| Domain | PI3/4_kinase_CS | 2.68e-03 | 15 | 97 | 2 | IPR018936 | |
| Domain | - | 3.06e-03 | 16 | 97 | 2 | 1.10.506.10 | |
| Domain | - | 3.06e-03 | 16 | 97 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.06e-03 | 16 | 97 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 3.87e-03 | 18 | 97 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.87e-03 | 18 | 97 | 2 | PF00454 | |
| Domain | RasGAP_dom | 3.87e-03 | 18 | 97 | 2 | IPR001936 | |
| Domain | PI3_4_KINASE_3 | 3.87e-03 | 18 | 97 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 3.87e-03 | 18 | 97 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.87e-03 | 18 | 97 | 2 | PS00916 | |
| Domain | BRCT | 4.31e-03 | 19 | 97 | 2 | PF00533 | |
| Domain | PDEase | 4.31e-03 | 19 | 97 | 2 | IPR023088 | |
| Domain | Myosin-like_IQ_dom | 4.31e-03 | 19 | 97 | 2 | IPR027401 | |
| Domain | - | 4.31e-03 | 19 | 97 | 2 | 4.10.270.10 | |
| Domain | - | 4.50e-03 | 207 | 97 | 5 | 1.25.40.10 | |
| Pathway | REACTOME_CELL_CYCLE | CCP110 CTC1 COP1 YWHAG YWHAH GOLGA8N AKAP9 DBF4 ANAPC2 ATM GOLGA8O DYNC1H1 TP53BP1 | 4.16e-05 | 603 | 82 | 13 | MM14635 |
| Pathway | REACTOME_CELL_CYCLE | CCP110 CTC1 SYNE1 COP1 YWHAG YWHAH AKAP9 DBF4 SYNE2 ANAPC2 ATM DYNC1H1 TP53BP1 KNL1 | 4.22e-05 | 694 | 82 | 14 | M543 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 4.71e-05 | 291 | 82 | 9 | M16647 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 4.85e-05 | 35 | 82 | 4 | M249 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 6.07e-05 | 37 | 82 | 4 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 6.07e-05 | 37 | 82 | 4 | MM15610 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 7.49e-05 | 39 | 82 | 4 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 8.29e-05 | 40 | 82 | 4 | M41816 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CCP110 IQGAP2 ESYT1 YWHAG YWHAH IQGAP1 GOLGA8N PTPN13 DST HGS CLTC GOLGA8O DYNC1H1 | 8.80e-05 | 649 | 82 | 13 | MM15690 |
| Pathway | BIOCARTA_CHEMICAL_PATHWAY | 1.45e-04 | 18 | 82 | 3 | M3873 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 1.66e-04 | 201 | 82 | 7 | M27472 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.75e-04 | 271 | 82 | 8 | MM15388 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | CCP110 IQGAP2 ESYT1 IQGAP1 GOLGA8N PTPN13 DST HGS CLTC GOLGA8O | 2.23e-04 | 439 | 82 | 10 | MM15595 |
| Pathway | WP_17P133_YWHAE_COPY_NUMBER_VARIATION | 2.34e-04 | 21 | 82 | 3 | M48088 | |
| Pathway | PID_P38_MK2_PATHWAY | 2.34e-04 | 21 | 82 | 3 | M199 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CCP110 IQGAP2 ESYT1 GOLGA8R YWHAG YWHAH IQGAP1 PTPN13 DST HGS CLTC DYNC1H1 KNL1 | 2.47e-04 | 720 | 82 | 13 | M41838 |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 2.66e-04 | 217 | 82 | 7 | MM14708 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 3.09e-04 | 23 | 82 | 3 | M39883 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 3.61e-04 | 105 | 82 | 5 | M164 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 4.47e-04 | 110 | 82 | 5 | MM15350 | |
| Pathway | WP_CELL_CYCLE | 6.65e-04 | 120 | 82 | 5 | M39650 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 7.68e-04 | 71 | 82 | 4 | MM15495 | |
| Pathway | KEGG_CELL_CYCLE | 8.00e-04 | 125 | 82 | 5 | M7963 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 8.10e-04 | 72 | 82 | 4 | M27749 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 8.10e-04 | 72 | 82 | 4 | MM15381 | |
| Pathway | BIOCARTA_PLK3_PATHWAY | 9.15e-04 | 8 | 82 | 2 | M22021 | |
| Pathway | WP_JOUBERT_SYNDROME | 9.93e-04 | 76 | 82 | 4 | M39835 | |
| Pathway | PID_ATM_PATHWAY | 9.97e-04 | 34 | 82 | 3 | M84 | |
| Pathway | BIOCARTA_CDC25_PATHWAY | 1.17e-03 | 9 | 82 | 2 | M22031 | |
| Pathway | WP_FAS_PATHWAY_AND_STRESS_INDUCTION_OF_HSP_REGULATION | 1.18e-03 | 36 | 82 | 3 | MM15967 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.18e-03 | 450 | 82 | 9 | M27078 | |
| Pubmed | USP34 CNST SYNE1 SPTBN2 GNPTG YWHAG YWHAH STAT1 FAF1 TXNDC11 IQGAP1 PTPN13 THOP1 DST CTR9 CLTC OSBPL1A MACF1 ATM UTRN DYNC1H1 | 1.32e-10 | 1285 | 102 | 21 | 35914814 | |
| Pubmed | NES IQGAP2 SYNE1 SPTBN2 YWHAG YWHAH IQGAP1 GOLGA8N EFTUD2 DST AKAP9 MTOR SYNE2 CLTC MACF1 GOLGA8O DYNC1H1 TP53BP1 | 3.99e-10 | 963 | 102 | 18 | 28671696 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | PDE4D IQGAP2 SYNE1 SPTBN2 YWHAG YWHAH IQGAP1 MTOR CLTC MACF1 DYNC1H1 | 7.32e-10 | 281 | 102 | 11 | 28706196 |
| Pubmed | USP34 NES SPTBN2 URB2 IQGAP1 DST MTOR SYNE2 CLTC MACF1 ATM UTRN DYNC1H1 TP53BP1 | 7.67e-09 | 653 | 102 | 14 | 22586326 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DYNC2H1 ESYT1 SYNE1 YWHAG YWHAH IQGAP1 EFTUD2 THOP1 DST AKAP9 CLTC MACF1 HSPA1L UTRN DYNC1H1 | 1.44e-08 | 807 | 102 | 15 | 30575818 |
| Pubmed | 2.08e-08 | 101 | 102 | 7 | 9872452 | ||
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 15949655 | ||
| Pubmed | Association of SNPs and haplotypes in APOL1, 2 and 4 with schizophrenia. | 2.45e-08 | 3 | 102 | 3 | 18632255 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES SYNE1 SPTBN2 URB2 YWHAG YWHAH STAT1 IQGAP1 EFTUD2 DST SYNE2 CLTC CSTF3 MACF1 UTRN DYNC1H1 | 5.04e-08 | 1024 | 102 | 16 | 24711643 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CCP110 IQGAP2 DYNC2H1 ESYT1 RDH10 BBS9 IQGAP1 EFTUD2 PTPN13 MTOR CTR9 OSBPL1A TTC21B TIMM29 LUM HSPA1L DYNC1H1 TP53BP1 | 5.32e-08 | 1321 | 102 | 18 | 27173435 |
| Pubmed | 6.82e-08 | 14 | 102 | 4 | 9373155 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NES ESYT1 INTS3 YWHAG YWHAH STAT1 FAF1 IQGAP1 EFTUD2 MTOR SYNE2 CLTC CSTF3 APOL2 HSPA1L UTRN TP53BP1 KNL1 | 8.87e-08 | 1367 | 102 | 18 | 32687490 |
| Pubmed | Mouse Apolipoprotein L9 is a phosphatidylethanolamine-binding protein. | 9.78e-08 | 4 | 102 | 3 | 27697524 | |
| Pubmed | β-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1. | 9.78e-08 | 4 | 102 | 3 | 26627735 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 11944986 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 20062082 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 11290834 | ||
| Pubmed | MYH8 NLRP7 RAPH1 IQGAP2 SYNE1 SPTBN2 KRBA2 YWHAG YWHAH IQGAP1 DST CTR9 SYNE2 CLTC MACF1 ATM HSPA1L DNAH8 | 1.96e-07 | 1442 | 102 | 18 | 35575683 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 NES RAPH1 ESYT1 RALGAPB YWHAG YWHAH PTPN13 DST AKAP9 MTOR SYNE2 MACF1 UTRN | 2.32e-07 | 861 | 102 | 14 | 36931259 |
| Pubmed | DYNC2H1 ESYT1 SYNE1 SPTBN2 RALGAPB EFTUD2 PTPN13 AKAP9 CDC123 CTR9 SYNE2 HGS CLTC MACF1 ATM USP48 HSPA1L TP53BP1 | 3.07e-07 | 1487 | 102 | 18 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PDE4D CACNA2D2 RALGAPB RDH10 ETV1 INTS3 NAALADL2 FAF1 PTPN13 THOP1 TTC21B KNDC1 CSTF3 MACF1 SPIDR UTRN MAML3 TMEM63A | 3.13e-07 | 1489 | 102 | 18 | 28611215 |
| Pubmed | 3.26e-07 | 20 | 102 | 4 | 21689717 | ||
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 4.23e-07 | 317 | 102 | 9 | 17620599 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDE4C RAPH1 RALGAPB SEMA5A INTS3 IQGAP1 EFTUD2 MED24 CTR9 DBF4 CLTC ATM TP53BP1 | 4.51e-07 | 774 | 102 | 13 | 15302935 |
| Pubmed | 4.74e-07 | 234 | 102 | 8 | 36243803 | ||
| Pubmed | 4.81e-07 | 322 | 102 | 9 | 26514267 | ||
| Pubmed | Differential gene expression during terminal erythroid differentiation. | 4.87e-07 | 6 | 102 | 3 | 17764892 | |
| Pubmed | The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. | 4.87e-07 | 6 | 102 | 3 | 11374903 | |
| Pubmed | Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice. | 7.08e-07 | 24 | 102 | 4 | 18434600 | |
| Pubmed | IQGAP2 COG7 ESYT1 IQGAP1 EFTUD2 MED24 CTR9 ANAPC2 CLTC CSTF3 DYNC1H1 | 8.13e-07 | 560 | 102 | 11 | 35241646 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 PDE4D COG7 YWHAG YWHAH STAT1 FAF1 IQGAP1 EFTUD2 THOP1 MTOR CTR9 HGS MACF1 USP48 HSPA1L DYNC1H1 | 1.11e-06 | 1455 | 102 | 17 | 22863883 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | INTS3 FAF1 IQGAP1 EFTUD2 ANAPC2 CSTF3 MACF1 ATM USP48 DYNC1H1 KNL1 | 1.18e-06 | 582 | 102 | 11 | 20467437 |
| Pubmed | NES MYH8 SYNE1 KRBA2 YWHAG YWHAH IQGAP1 DST CLTC MACF1 HSPA1L UTRN DYNC1H1 | 1.18e-06 | 844 | 102 | 13 | 25963833 | |
| Pubmed | COP1 is a tumour suppressor that causes degradation of ETS transcription factors. | 1.36e-06 | 8 | 102 | 3 | 21572435 | |
| Pubmed | CCP110 DYNC2H1 SPTBN2 EFTUD2 TTC21B MACF1 GRIN3A SPIDR MAML3 TMEM63A | 1.99e-06 | 493 | 102 | 10 | 15368895 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 2.18e-06 | 498 | 102 | 10 | 36634849 | |
| Pubmed | RAPH1 SPTBN2 RALGAPB YWHAG YWHAH PTPN13 AKAP9 CTR9 SYNE2 HGS CLTC CSTF3 UTRN KNL1 | 2.39e-06 | 1049 | 102 | 14 | 27880917 | |
| Pubmed | COG7 ESYT1 YWHAG FAF1 IQGAP1 EFTUD2 MTOR CTR9 CLTC CSTF3 DYNC1H1 | 2.86e-06 | 638 | 102 | 11 | 33239621 | |
| Pubmed | 3.08e-06 | 76 | 102 | 5 | 27542412 | ||
| Pubmed | USP34 PRAMEF33 IQGAP2 CNST CTC1 STAT1 MED24 PTPN13 THOP1 CTR9 CLTC MACF1 UTRN TP53BP1 | 3.49e-06 | 1084 | 102 | 14 | 11544199 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DYNC2H1 ESYT1 URB2 YWHAH FAF1 IQGAP1 MED24 MTOR ANAPC2 CLTC CSTF3 TIMM29 DYNC1H1 | 3.94e-06 | 942 | 102 | 13 | 31073040 |
| Pubmed | USP34 IQGAP2 COG7 ESYT1 SPTBN2 GNPTG YWHAG YWHAH IQGAP1 EFTUD2 DST MTOR SYNE2 CLTC ATM DYNC1H1 | 4.53e-06 | 1440 | 102 | 16 | 30833792 | |
| Pubmed | 4.96e-06 | 147 | 102 | 6 | 16959763 | ||
| Pubmed | 5.79e-06 | 151 | 102 | 6 | 17043677 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 5.97e-06 | 329 | 102 | 8 | 34316702 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 6.38e-06 | 332 | 102 | 8 | 32786267 | |
| Pubmed | 6.50e-06 | 41 | 102 | 4 | 8590280 | ||
| Pubmed | 6.92e-06 | 446 | 102 | 9 | 24255178 | ||
| Pubmed | 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells. | 8.52e-06 | 2 | 102 | 2 | 27613518 | |
| Pubmed | ATM and 53BP1 regulate alternative end joining-mediated V(D)J recombination. | 8.52e-06 | 2 | 102 | 2 | 39083600 | |
| Pubmed | Structures of the ApoL1 and ApoL2 N-terminal domains reveal a non-classical four-helix bundle motif. | 8.52e-06 | 2 | 102 | 2 | 34316015 | |
| Pubmed | COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer. | 8.52e-06 | 2 | 102 | 2 | 25884720 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11792814 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11002341 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 8.52e-06 | 2 | 102 | 2 | 24931616 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23858098 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16720641 | ||
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 8.52e-06 | 2 | 102 | 2 | 16440056 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 39226322 | ||
| Pubmed | Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1. | 8.52e-06 | 2 | 102 | 2 | 11042216 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18996087 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22768332 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 24998570 | ||
| Pubmed | IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. | 8.52e-06 | 2 | 102 | 2 | 20977743 | |
| Pubmed | The association of 14-3-3gamma and actin plays a role in cell division and apoptosis in astrocytes. | 8.52e-06 | 2 | 102 | 2 | 12176032 | |
| Pubmed | Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice. | 8.52e-06 | 2 | 102 | 2 | 37043976 | |
| Pubmed | The role of ATM and 53BP1 as predictive markers in cervical cancer. | 8.52e-06 | 2 | 102 | 2 | 22323184 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 8.52e-06 | 2 | 102 | 2 | 17267447 | |
| Pubmed | Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. | 8.52e-06 | 2 | 102 | 2 | 18180285 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 8.52e-06 | 2 | 102 | 2 | 24718612 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 24586179 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25502651 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17761684 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 31578382 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15279780 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11532964 | ||
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 8.66e-06 | 162 | 102 | 6 | 14743216 | |
| Pubmed | 8.71e-06 | 14 | 102 | 3 | 19874786 | ||
| Pubmed | 8.71e-06 | 14 | 102 | 3 | 34380029 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 CCP110 DYNC2H1 CTR9 CLTC MACF1 PPP2R3C HSPA1L TP53BP1 KNL1 | 9.35e-06 | 588 | 102 | 10 | 38580884 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES ESYT1 URB2 YWHAG STAT1 IQGAP1 EFTUD2 DST CTR9 CLTC MACF1 HSPA1L UTRN DYNC1H1 TP53BP1 | 9.54e-06 | 1353 | 102 | 15 | 29467282 |
| Pubmed | 9.67e-06 | 251 | 102 | 7 | 27507650 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.10e-05 | 256 | 102 | 7 | 33397691 | |
| Pubmed | 1.13e-05 | 47 | 102 | 4 | 8812413 | ||
| Pubmed | 1.33e-05 | 16 | 102 | 3 | 30322923 | ||
| Pubmed | 1.37e-05 | 486 | 102 | 9 | 20936779 | ||
| Pubmed | 1.43e-05 | 177 | 102 | 6 | 26485645 | ||
| Pubmed | 1.63e-05 | 497 | 102 | 9 | 23414517 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CACNA2D2 DYNC2H1 ESYT1 SYNE1 URB2 STAT1 IQGAP1 EFTUD2 MTOR CTR9 CLTC CSTF3 ATM DNAH5 DYNC1H1 | 1.75e-05 | 1425 | 102 | 15 | 30948266 |
| Pubmed | Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase. | 1.94e-05 | 18 | 102 | 3 | 30240640 | |
| Pubmed | 1.94e-05 | 18 | 102 | 3 | 24227724 | ||
| Pubmed | Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. | 1.94e-05 | 18 | 102 | 3 | 25117710 | |
| Pubmed | 1.96e-05 | 187 | 102 | 6 | 26460568 | ||
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 1.97e-05 | 54 | 102 | 4 | 21525035 | |
| Pubmed | 2.12e-05 | 55 | 102 | 4 | 29997285 | ||
| Pubmed | 2.20e-05 | 191 | 102 | 6 | 33762435 | ||
| Pubmed | The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. | 2.28e-05 | 56 | 102 | 4 | 11076968 | |
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 2.29e-05 | 19 | 102 | 3 | 17664336 | |
| Pubmed | 2.31e-05 | 397 | 102 | 8 | 21319273 | ||
| Pubmed | 2.34e-05 | 288 | 102 | 7 | 23383273 | ||
| Interaction | YWHAZ interactions | CCP110 PDE4D RAPH1 ESYT1 SPTBN2 RALGAPB COP1 YWHAG YWHAH FAF1 EFTUD2 PTPN13 DST AKAP9 CDC123 MTOR SYNE2 CLTC MACF1 ATM USP48 DYNC1H1 TP53BP1 | 6.12e-08 | 1319 | 98 | 23 | int:YWHAZ |
| Interaction | MYCBP2 interactions | NES SPTBN2 COP1 YWHAG YWHAH FAF1 IQGAP1 DST MTOR SYNE2 MACF1 DYNC1H1 | 1.55e-07 | 355 | 98 | 12 | int:MYCBP2 |
| Interaction | PCNT interactions | SYNE1 SPTBN2 YWHAH TXNDC11 DST AKAP9 ANAPC2 MACF1 UTRN TP53BP1 | 2.77e-07 | 241 | 98 | 10 | int:PCNT |
| Interaction | YWHAB interactions | CCP110 ESYT1 RALGAPB COP1 YWHAG YWHAH IQGAP1 EFTUD2 PTPN13 DST AKAP9 CDC123 MTOR CTR9 HGS CLTC MACF1 USP48 DYNC1H1 | 3.60e-07 | 1014 | 98 | 19 | int:YWHAB |
| Interaction | DSCAM interactions | 1.88e-06 | 171 | 98 | 8 | int:DSCAM | |
| Interaction | YWHAG interactions | CCP110 RAPH1 ESYT1 RALGAPB YWHAG YWHAH FAF1 IQGAP1 EFTUD2 PTPN13 DST AKAP9 CDC123 MTOR SYNE2 CLTC MACF1 USP48 UTRN DYNC1H1 | 1.96e-06 | 1248 | 98 | 20 | int:YWHAG |
| Interaction | VCL interactions | 2.35e-06 | 305 | 98 | 10 | int:VCL | |
| Interaction | SYNGAP1 interactions | IQGAP2 SPTBN2 YWHAG YWHAH IQGAP1 MTOR SYNE2 CLTC DYNC1H1 TP53BP1 | 2.49e-06 | 307 | 98 | 10 | int:SYNGAP1 |
| Interaction | MORC3 interactions | 2.55e-06 | 80 | 98 | 6 | int:MORC3 | |
| Interaction | C11orf52 interactions | 2.80e-06 | 311 | 98 | 10 | int:C11orf52 | |
| Interaction | APC interactions | SYNE1 SPTBN2 YWHAG YWHAH IQGAP1 PTPN13 DST ANAPC2 HGS MACF1 RP1 | 3.00e-06 | 389 | 98 | 11 | int:APC |
| Interaction | RAC1 interactions | RAPH1 IQGAP2 ESYT1 SPTBN2 RALGAPB GOLGA8R YWHAG STAT1 IQGAP1 PTPN13 DST CDC123 MTOR HACE1 CLTC MACF1 USP48 UTRN | 3.23e-06 | 1063 | 98 | 18 | int:RAC1 |
| Interaction | SPTAN1 interactions | PDE4D SPTBN2 YWHAG YWHAH STAT1 IQGAP1 EFTUD2 DST CDC123 SYNE2 CLTC USP48 | 5.16e-06 | 496 | 98 | 12 | int:SPTAN1 |
| Interaction | YWHAH interactions | CCP110 NES ESYT1 RALGAPB YWHAG YWHAH FAF1 IQGAP1 EFTUD2 PTPN13 DST AKAP9 CDC123 MTOR SYNE2 MACF1 USP48 UTRN | 5.34e-06 | 1102 | 98 | 18 | int:YWHAH |
| Interaction | MCMBP interactions | 1.16e-05 | 157 | 98 | 7 | int:MCMBP | |
| Interaction | RHOJ interactions | IQGAP2 ESYT1 SPTBN2 RALGAPB YWHAG YWHAH IQGAP1 PTPN13 MTOR HGS CLTC MACF1 UTRN | 1.19e-05 | 633 | 98 | 13 | int:RHOJ |
| Interaction | MAPK1 interactions | USP34 PDE4D COP1 CASP9 IQGAP1 EFTUD2 CDC123 MTOR SYNE2 ATM USP48 TP53BP1 | 1.28e-05 | 543 | 98 | 12 | int:MAPK1 |
| Interaction | ARRB2 interactions | PDE4D YWHAG YWHAH STAT1 EFTUD2 DNAAF8 SYNE2 HGS CLTC HSPA1L DYNC1H1 | 1.29e-05 | 454 | 98 | 11 | int:ARRB2 |
| Interaction | SIRT7 interactions | USP34 NES SPTBN2 URB2 IQGAP1 DST MTOR SYNE2 CLTC MACF1 ATM UTRN DYNC1H1 TP53BP1 | 1.43e-05 | 744 | 98 | 14 | int:SIRT7 |
| Interaction | TNIK interactions | NES SYNE1 SPTBN2 EFTUD2 DST AKAP9 SYNE2 MACF1 DYNC1H1 TP53BP1 | 1.66e-05 | 381 | 98 | 10 | int:TNIK |
| Interaction | DCP1A interactions | 1.67e-05 | 166 | 98 | 7 | int:DCP1A | |
| Interaction | TTK interactions | 2.18e-05 | 173 | 98 | 7 | int:TTK | |
| Interaction | BRCA1 interactions | SDK2 CTC1 ETV5 CASP9 LRRK1 STAT1 IQGAP1 EFTUD2 DST MTOR DBF4 CLTC ATM USP48 HSPA1L DYNC1H1 TP53BP1 KNL1 | 2.91e-05 | 1249 | 98 | 18 | int:BRCA1 |
| Interaction | OBSL1 interactions | NES SYNE1 SPTBN2 URB2 IQGAP1 EFTUD2 DNAAF8 DST CDC123 SYNE2 ANAPC2 CLTC MACF1 UTRN DYNC1H1 | 2.92e-05 | 902 | 98 | 15 | int:OBSL1 |
| Interaction | PPP1CA interactions | NLRP7 CNST YWHAG YWHAH IQGAP1 EFTUD2 AKAP9 CDC123 CLTC ATM HSPA1L DYNC1H1 KNL1 | 3.21e-05 | 696 | 98 | 13 | int:PPP1CA |
| Interaction | KRT18 interactions | 3.72e-05 | 419 | 98 | 10 | int:KRT18 | |
| Interaction | PRR5 interactions | 3.79e-05 | 39 | 98 | 4 | int:PRR5 | |
| Interaction | MCM5 interactions | 3.80e-05 | 420 | 98 | 10 | int:MCM5 | |
| Interaction | SPTBN1 interactions | SPTBN2 YWHAG YWHAH STAT1 IQGAP1 EFTUD2 CDC123 SYNE2 CLTC USP48 | 3.88e-05 | 421 | 98 | 10 | int:SPTBN1 |
| Interaction | ABL1 interactions | 3.88e-05 | 259 | 98 | 8 | int:ABL1 | |
| Interaction | FGD6 interactions | 4.20e-05 | 40 | 98 | 4 | int:FGD6 | |
| Interaction | SNCA interactions | NES RAPH1 IQGAP2 ESYT1 YWHAH STAT1 EFTUD2 DST SYNE2 CLTC MACF1 HSPA1L DYNC1H1 | 4.30e-05 | 716 | 98 | 13 | int:SNCA |
| Interaction | AGR2 interactions | DYNC2H1 ESYT1 SYNE1 YWHAG YWHAH IQGAP1 EFTUD2 THOP1 DST AKAP9 CLTC MACF1 HSPA1L UTRN DYNC1H1 | 4.36e-05 | 934 | 98 | 15 | int:AGR2 |
| Interaction | ATOH1 interactions | 4.42e-05 | 80 | 98 | 5 | int:ATOH1 | |
| Interaction | LIMA1 interactions | 4.54e-05 | 429 | 98 | 10 | int:LIMA1 | |
| Interaction | LYN interactions | CCP110 SDK2 PDE4D IQGAP2 ESYT1 SPTBN2 CASP9 IQGAP1 EFTUD2 PTPN13 DST MACF1 UTRN | 4.55e-05 | 720 | 98 | 13 | int:LYN |
| Interaction | SIPA1 interactions | 4.64e-05 | 41 | 98 | 4 | int:SIPA1 | |
| Interaction | MTNR1B interactions | 5.13e-05 | 135 | 98 | 6 | int:MTNR1B | |
| Interaction | RHOB interactions | SDK2 RAPH1 IQGAP2 ESYT1 SPTBN2 RALGAPB YWHAG IQGAP1 PTPN13 HGS CLTC MACF1 GOLGA8O UTRN | 5.41e-05 | 840 | 98 | 14 | int:RHOB |
| Interaction | CLASP1 interactions | 5.80e-05 | 138 | 98 | 6 | int:CLASP1 | |
| Interaction | RHOQ interactions | IQGAP2 ESYT1 SPTBN2 RALGAPB IQGAP1 PTPN13 DST MTOR CLTC UTRN | 5.83e-05 | 442 | 98 | 10 | int:RHOQ |
| Interaction | CDC42 interactions | RAPH1 IQGAP2 DYNC2H1 ESYT1 SYNE1 SPTBN2 RALGAPB GOLGA8R URB2 YWHAG YWHAH STAT1 IQGAP1 PTPN13 CDC123 SYNE2 CLTC UTRN | 6.16e-05 | 1323 | 98 | 18 | int:CDC42 |
| Interaction | NPTN interactions | 6.38e-05 | 278 | 98 | 8 | int:NPTN | |
| Interaction | CDC5L interactions | SYNE1 INTS3 YWHAG FAF1 IQGAP1 EFTUD2 DST AKAP9 ANAPC2 CSTF3 MACF1 HSPA1L DYNC1H1 KNL1 | 6.54e-05 | 855 | 98 | 14 | int:CDC5L |
| Interaction | DLG4 interactions | 6.64e-05 | 449 | 98 | 10 | int:DLG4 | |
| Interaction | CYBB interactions | 7.34e-05 | 46 | 98 | 4 | int:CYBB | |
| Interaction | AGAP2 interactions | 7.49e-05 | 210 | 98 | 7 | int:AGAP2 | |
| Interaction | GSK3B interactions | CCP110 ZNF135 PDE4D IQGAP1 EFTUD2 MED24 PTPN13 DST CDC123 MTOR CLTC MACF1 USP48 UTRN | 7.68e-05 | 868 | 98 | 14 | int:GSK3B |
| Interaction | NINL interactions | CCP110 DYNC2H1 YWHAG YWHAH IQGAP1 PTPN13 ANAPC2 CLTC HSPA1L DYNC1H1 | 7.83e-05 | 458 | 98 | 10 | int:NINL |
| Interaction | CLASP2 interactions | 8.24e-05 | 147 | 98 | 6 | int:CLASP2 | |
| Interaction | HSPA4 interactions | CCP110 YWHAG YWHAH FAF1 EFTUD2 CDC123 MTOR CLTC USP48 HSPA1L DNAH8 KNL1 | 9.44e-05 | 667 | 98 | 12 | int:HSPA4 |
| Interaction | PLEKHA2 interactions | 9.56e-05 | 94 | 98 | 5 | int:PLEKHA2 | |
| Interaction | STIP1 interactions | COG7 ESYT1 YWHAG FAF1 IQGAP1 EFTUD2 CDC123 MTOR CTR9 ANAPC2 CLTC CSTF3 USP48 HSPA1L DYNC1H1 | 1.01e-04 | 1006 | 98 | 15 | int:STIP1 |
| Interaction | SASH1 interactions | 1.02e-04 | 50 | 98 | 4 | int:SASH1 | |
| Interaction | RHOD interactions | ESYT1 SPTBN2 RALGAPB GOLGA8R IQGAP1 PTPN13 MTOR SYNE2 CLTC MACF1 UTRN | 1.05e-04 | 572 | 98 | 11 | int:RHOD |
| Interaction | KRT77 interactions | 1.06e-04 | 96 | 98 | 5 | int:KRT77 | |
| Interaction | CDK2 interactions | CCP110 PDE4D COG7 ESYT1 YWHAG YWHAH IQGAP1 EFTUD2 DST CDC123 DBF4 CLTC DYNC1H1 | 1.06e-04 | 783 | 98 | 13 | int:CDK2 |
| Interaction | ARRB1 interactions | 1.19e-04 | 304 | 98 | 8 | int:ARRB1 | |
| Interaction | DCLRE1A interactions | 1.20e-04 | 20 | 98 | 3 | int:DCLRE1A | |
| Interaction | MLXIP interactions | 1.20e-04 | 20 | 98 | 3 | int:MLXIP | |
| Interaction | SPIRE2 interactions | 1.39e-04 | 21 | 98 | 3 | int:SPIRE2 | |
| Interaction | SUMO2 interactions | INTS3 YWHAG IQGAP1 EFTUD2 DST CTR9 ANAPC2 CLTC USP48 DYNC1H1 TP53BP1 | 1.40e-04 | 591 | 98 | 11 | int:SUMO2 |
| Interaction | NDC80 interactions | 1.42e-04 | 312 | 98 | 8 | int:NDC80 | |
| Interaction | NDEL1 interactions | 1.50e-04 | 164 | 98 | 6 | int:NDEL1 | |
| Interaction | MDM4 interactions | 1.61e-04 | 105 | 98 | 5 | int:MDM4 | |
| Interaction | OTUD7A interactions | 1.82e-04 | 58 | 98 | 4 | int:OTUD7A | |
| Interaction | STK40 interactions | 1.82e-04 | 58 | 98 | 4 | int:STK40 | |
| Interaction | DHX38 interactions | 1.83e-04 | 170 | 98 | 6 | int:DHX38 | |
| Interaction | RHOU interactions | ESYT1 SPTBN2 RALGAPB IQGAP1 PTPN13 DST CDC123 HGS CLTC MACF1 | 1.88e-04 | 510 | 98 | 10 | int:RHOU |
| Interaction | CHEK1 interactions | 1.95e-04 | 245 | 98 | 7 | int:CHEK1 | |
| Interaction | KLC2 interactions | 1.95e-04 | 172 | 98 | 6 | int:KLC2 | |
| Interaction | C9orf78 interactions | IQGAP2 COG7 ESYT1 IQGAP1 EFTUD2 MED24 CTR9 ANAPC2 CLTC CSTF3 DYNC1H1 | 2.12e-04 | 620 | 98 | 11 | int:C9orf78 |
| Interaction | OPTN interactions | 2.16e-04 | 422 | 98 | 9 | int:OPTN | |
| Interaction | HSP90AB1 interactions | LRRK1 YWHAG YWHAH GOLGA8Q STAT1 FAF1 IQGAP1 EFTUD2 THOP1 NOD1 CDC123 MTOR USP48 HSPA1L | 2.20e-04 | 960 | 98 | 14 | int:HSP90AB1 |
| Interaction | MCM2 interactions | MYH8 SYNE1 KRBA2 YWHAG YWHAH IQGAP1 EFTUD2 DST DBF4 CLTC MACF1 ATM HSPA1L UTRN DYNC1H1 | 2.21e-04 | 1081 | 98 | 15 | int:MCM2 |
| Interaction | CRTC2 interactions | 2.22e-04 | 61 | 98 | 4 | int:CRTC2 | |
| Interaction | DNAJC7 interactions | 2.28e-04 | 425 | 98 | 9 | int:DNAJC7 | |
| Interaction | TUBB interactions | CCP110 NLRP7 COP1 YWHAG FAF1 IQGAP1 EFTUD2 CDC123 MTOR HGS USP48 DYNC1H1 | 2.33e-04 | 735 | 98 | 12 | int:TUBB |
| Interaction | PFKFB2 interactions | 2.36e-04 | 62 | 98 | 4 | int:PFKFB2 | |
| Interaction | CAPZA2 interactions | 2.48e-04 | 430 | 98 | 9 | int:CAPZA2 | |
| Interaction | TERF2 interactions | 2.55e-04 | 340 | 98 | 8 | int:TERF2 | |
| Interaction | SLK interactions | 2.72e-04 | 183 | 98 | 6 | int:SLK | |
| Interaction | RSU1 interactions | 2.84e-04 | 65 | 98 | 4 | int:RSU1 | |
| Interaction | HUWE1 interactions | USP34 NES ESYT1 YWHAG YWHAH STAT1 IQGAP1 EFTUD2 AKAP9 CDC123 CLTC MACF1 ATM DYNC1H1 TP53BP1 | 2.93e-04 | 1110 | 98 | 15 | int:HUWE1 |
| Interaction | LAMP1 interactions | ESYT1 SPTBN2 RALGAPB YWHAH IQGAP1 PTPN13 DST CDC123 MTOR HGS MACF1 | 2.94e-04 | 644 | 98 | 11 | int:LAMP1 |
| Interaction | ERGIC1 interactions | 3.07e-04 | 264 | 98 | 7 | int:ERGIC1 | |
| Interaction | CARMIL2 interactions | 3.34e-04 | 28 | 98 | 3 | int:CARMIL2 | |
| Interaction | HSPH1 interactions | 3.35e-04 | 448 | 98 | 9 | int:HSPH1 | |
| Interaction | MAP7D3 interactions | 3.37e-04 | 123 | 98 | 5 | int:MAP7D3 | |
| Interaction | MCM3 interactions | 3.40e-04 | 355 | 98 | 8 | int:MCM3 | |
| Interaction | CCDC8 interactions | SPTBN2 YWHAG YWHAH STAT1 IQGAP1 EFTUD2 DST CLTC MACF1 UTRN DYNC1H1 | 3.44e-04 | 656 | 98 | 11 | int:CCDC8 |
| Interaction | LINC02694 interactions | 3.47e-04 | 6 | 98 | 2 | int:LINC02694 | |
| Interaction | ABCF3 interactions | 3.50e-04 | 124 | 98 | 5 | int:ABCF3 | |
| Interaction | FOXO3 interactions | 3.50e-04 | 124 | 98 | 5 | int:FOXO3 | |
| Interaction | MAP3K10 interactions | 3.57e-04 | 69 | 98 | 4 | int:MAP3K10 | |
| Interaction | KLC4 interactions | 3.63e-04 | 125 | 98 | 5 | int:KLC4 | |
| Interaction | FTCD interactions | 3.72e-04 | 29 | 98 | 3 | int:FTCD | |
| Interaction | CKAP2 interactions | 3.77e-04 | 126 | 98 | 5 | int:CKAP2 | |
| Interaction | MTMR3 interactions | 3.77e-04 | 70 | 98 | 4 | int:MTMR3 | |
| Interaction | ST13 interactions | 3.82e-04 | 195 | 98 | 6 | int:ST13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 7.64e-05 | 100 | 102 | 4 | chr15q13 | |
| Cytoband | 17p13.1 | 1.45e-04 | 118 | 102 | 4 | 17p13.1 | |
| Cytoband | 17q21.1 | 9.05e-04 | 20 | 102 | 2 | 17q21.1 | |
| Cytoband | 15q13.2 | 9.99e-04 | 21 | 102 | 2 | 15q13.2 | |
| Cytoband | 5p15.2 | 1.65e-03 | 27 | 102 | 2 | 5p15.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q12 | 1.92e-03 | 235 | 102 | 4 | chr22q12 | |
| GeneFamily | Apolipoproteins | 7.03e-05 | 21 | 70 | 3 | 405 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 8.82e-05 | 4 | 70 | 2 | 1252 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 3.06e-04 | 7 | 70 | 2 | 1053 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.08e-04 | 8 | 70 | 2 | 939 | |
| GeneFamily | Dyneins, cytoplasmic | 1.12e-03 | 13 | 70 | 2 | 538 | |
| GeneFamily | Dyneins, axonemal | 1.94e-03 | 17 | 70 | 2 | 536 | |
| GeneFamily | Phosphodiesterases | 3.86e-03 | 24 | 70 | 2 | 681 | |
| GeneFamily | NLR family | 4.18e-03 | 25 | 70 | 2 | 666 | |
| GeneFamily | ETS transcription factor family | 5.23e-03 | 28 | 70 | 2 | 534 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.33e-03 | 181 | 70 | 4 | 694 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 5.99e-03 | 30 | 70 | 2 | 959 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.49e-07 | 212 | 102 | 9 | M39221 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 1.09e-06 | 86 | 102 | 6 | M39248 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 7.89e-06 | 184 | 102 | 7 | M9005 | |
| Coexpression | GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN | 9.73e-06 | 190 | 102 | 7 | M5666 | |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | CCP110 IQGAP2 DYNC2H1 COG7 SYNE1 BBS9 YWHAH DNAAF8 AKAP9 SYNE2 TTC21B KNDC1 RP1 DNAH5 TP53BP1 | 2.12e-05 | 1093 | 102 | 15 | M41649 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 4.64e-05 | 165 | 102 | 6 | M8121 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 5.67e-05 | 171 | 102 | 6 | M39234 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 6.86e-05 | 177 | 102 | 6 | M39245 | |
| Coexpression | GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 1.14e-04 | 194 | 102 | 6 | M8017 | |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.24e-04 | 197 | 102 | 6 | M5347 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN | 1.31e-04 | 199 | 102 | 6 | M4571 | |
| Coexpression | GSE39022_LN_VS_SPLEEN_DC_UP | 1.31e-04 | 199 | 102 | 6 | M9017 | |
| Coexpression | GSE3982_MAST_CELL_VS_MAC_UP | 1.31e-04 | 199 | 102 | 6 | M5429 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 1.34e-04 | 200 | 102 | 6 | M7776 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 1.34e-04 | 200 | 102 | 6 | M6621 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN | 1.34e-04 | 200 | 102 | 6 | M3885 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 1.39e-04 | 26 | 102 | 3 | M1380 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.68e-10 | 199 | 102 | 9 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.68e-10 | 199 | 102 | 9 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.68e-10 | 199 | 102 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.67e-08 | 195 | 102 | 8 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.81e-08 | 197 | 102 | 8 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.88e-08 | 198 | 102 | 8 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.88e-08 | 198 | 102 | 8 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.95e-08 | 199 | 102 | 8 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.95e-08 | 199 | 102 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.95e-08 | 199 | 102 | 8 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.03e-08 | 200 | 102 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.03e-08 | 200 | 102 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.03e-08 | 200 | 102 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.03e-08 | 200 | 102 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 2.03e-08 | 200 | 102 | 8 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 2.27e-07 | 184 | 102 | 7 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.82e-07 | 190 | 102 | 7 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 3.03e-07 | 192 | 102 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.03e-07 | 192 | 102 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.14e-07 | 193 | 102 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.14e-07 | 193 | 102 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 195 | 102 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 195 | 102 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.48e-07 | 196 | 102 | 7 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.48e-07 | 196 | 102 | 7 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.48e-07 | 196 | 102 | 7 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.48e-07 | 196 | 102 | 7 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.60e-07 | 197 | 102 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.60e-07 | 197 | 102 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.60e-07 | 197 | 102 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-07 | 198 | 102 | 7 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-07 | 198 | 102 | 7 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-07 | 198 | 102 | 7 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.73e-07 | 198 | 102 | 7 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class | 3.73e-07 | 198 | 102 | 7 | 6aea5d00c417708f05b6d2dfe5a962d80864f8eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.86e-07 | 199 | 102 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.86e-07 | 199 | 102 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.86e-07 | 199 | 102 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 3.99e-07 | 200 | 102 | 7 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 3.99e-07 | 200 | 102 | 7 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.99e-07 | 200 | 102 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.99e-07 | 200 | 102 | 7 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.99e-07 | 200 | 102 | 7 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.99e-07 | 200 | 102 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.99e-07 | 200 | 102 | 7 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.75e-06 | 171 | 102 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-06 | 173 | 102 | 6 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.14e-06 | 175 | 102 | 6 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-06 | 178 | 102 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-06 | 179 | 102 | 6 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 3.69e-06 | 180 | 102 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.06e-06 | 183 | 102 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-06 | 183 | 102 | 6 | d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.33e-06 | 185 | 102 | 6 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.74e-06 | 188 | 102 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-06 | 189 | 102 | 6 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-06 | 189 | 102 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-06 | 189 | 102 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.04e-06 | 190 | 102 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 190 | 102 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.35e-06 | 192 | 102 | 6 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.51e-06 | 193 | 102 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.51e-06 | 193 | 102 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.51e-06 | 193 | 102 | 6 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.51e-06 | 193 | 102 | 6 | 8187f976fd2d11fad3286690f1a046e894772220 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.51e-06 | 193 | 102 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.68e-06 | 194 | 102 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 5.85e-06 | 195 | 102 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.85e-06 | 195 | 102 | 6 | b0cea3f4e59635913d243612f2e8cf4c7b34e726 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.85e-06 | 195 | 102 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 5.85e-06 | 195 | 102 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.02e-06 | 196 | 102 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.02e-06 | 196 | 102 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.20e-06 | 197 | 102 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.20e-06 | 197 | 102 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-06 | 197 | 102 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.38e-06 | 198 | 102 | 6 | 92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.38e-06 | 198 | 102 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.57e-06 | 199 | 102 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.57e-06 | 199 | 102 | 6 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.57e-06 | 199 | 102 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.76e-06 | 200 | 102 | 6 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.76e-06 | 200 | 102 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.76e-06 | 200 | 102 | 6 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.76e-06 | 200 | 102 | 6 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 8.75e-06 | 121 | 102 | 5 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-05 | 130 | 102 | 5 | 0f9d3e6297f48ae14d24ac997d8d3a94f337d4d4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.24e-05 | 130 | 102 | 5 | fc68a648161dd314d9ee6612fd039cb12171b8c6 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.49e-05 | 135 | 102 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.03e-05 | 144 | 102 | 5 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 153 | 102 | 5 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 157 | 102 | 5 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-05 | 160 | 102 | 5 | 7064af50fc10e3ea03badf415306222b74db0f95 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 161 | 102 | 5 | 3e5a125a25d55bf27652f456239b00b315d54d91 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.58e-05 | 162 | 102 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.37e-05 | 169 | 102 | 5 | f06118754fa62c580b4bcbecff6f9e5fdc2106a0 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.63e-05 | 171 | 102 | 5 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.45e-05 | 177 | 102 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.45e-05 | 177 | 102 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 5.45e-05 | 177 | 102 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.94e-09 | 49 | 54 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-04 | 50 | 54 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | plakin | 2.42e-09 | 82 | 98 | 8 | CID000018752 | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.55e-06 | 188 | 98 | 8 | 4545_DN | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.20e-06 | 197 | 98 | 8 | 3784_DN | |
| Disease | Ciliopathies | 2.91e-05 | 110 | 95 | 5 | C4277690 | |
| Disease | Jeune thoracic dystrophy | 6.13e-05 | 4 | 95 | 2 | cv:C0265275 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 6.13e-05 | 4 | 95 | 2 | cv:CN293514 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 6.13e-05 | 4 | 95 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.02e-04 | 5 | 95 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.02e-04 | 5 | 95 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.53e-04 | 6 | 95 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.53e-04 | 6 | 95 | 2 | C0410189 | |
| Disease | bipolar disorder (implicated_via_orthology) | 2.13e-04 | 7 | 95 | 2 | DOID:3312 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.13e-04 | 7 | 95 | 2 | C0751337 | |
| Disease | multisite chronic pain | 2.57e-04 | 95 | 95 | 4 | EFO_0010100 | |
| Disease | kidney disease (implicated_via_orthology) | 3.15e-04 | 41 | 95 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | aplastic anemia (is_marker_for) | 3.64e-04 | 9 | 95 | 2 | DOID:12449 (is_marker_for) | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 4.16e-04 | 45 | 95 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | Jeune thoracic dystrophy | 5.54e-04 | 11 | 95 | 2 | C0265275 | |
| Disease | SCHIZOPHRENIA | 5.54e-04 | 11 | 95 | 2 | 181500 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 6.63e-04 | 12 | 95 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | niacinamide measurement | 6.63e-04 | 12 | 95 | 2 | EFO_0010511 | |
| Disease | Malignant neoplasm of breast | RAPH1 DYNC2H1 SYNE1 APOL1 STAT1 AKAP9 MTOR SYNE2 MACF1 ATM TP53BP1 | 6.76e-04 | 1074 | 95 | 11 | C0006142 |
| Disease | Short Rib-Polydactyly Syndrome | 7.82e-04 | 13 | 95 | 2 | C0036996 | |
| Disease | Malformations of Cortical Development | 9.10e-04 | 14 | 95 | 2 | C1955869 | |
| Disease | Saldino-Noonan Syndrome | 9.10e-04 | 14 | 95 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 9.10e-04 | 14 | 95 | 2 | C0024507 | |
| Disease | Cortical Dysplasia | 9.10e-04 | 14 | 95 | 2 | C0431380 | |
| Disease | sleep measurement | 9.67e-04 | 135 | 95 | 4 | EFO_0004870 | |
| Disease | chronic kidney disease | 9.94e-04 | 235 | 95 | 5 | EFO_0003884 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.05e-03 | 15 | 95 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.05e-03 | 15 | 95 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.05e-03 | 15 | 95 | 2 | C0154091 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.20e-03 | 16 | 95 | 2 | C0334634 | |
| Disease | body mass index, type 2 diabetes mellitus | 1.20e-03 | 16 | 95 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | intraocular pressure measurement | 1.31e-03 | 509 | 95 | 7 | EFO_0004695 | |
| Disease | sphingomyelin 14:0 measurement | 1.35e-03 | 17 | 95 | 2 | EFO_0010390 | |
| Disease | Carcinoma of bladder | 1.52e-03 | 18 | 95 | 2 | C0699885 | |
| Disease | Schizophrenia | 1.52e-03 | 18 | 95 | 2 | cv:C0036341 | |
| Disease | alkaline phosphatase measurement | USP34 PDE4C TXNDC11 MED24 MACF1 RP1 APOL2 USP48 UTRN TP53BP1 | 1.60e-03 | 1015 | 95 | 10 | EFO_0004533 |
| Disease | unipolar depression, bipolar disorder | 1.65e-03 | 156 | 95 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.69e-03 | 157 | 95 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | schizophrenia (is_implicated_in) | 2.07e-03 | 78 | 95 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | Schizophrenia | 2.19e-03 | 883 | 95 | 9 | C0036341 | |
| Disease | blood phosphate measurement | 2.45e-03 | 174 | 95 | 4 | EFO_0010972 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.70e-03 | 24 | 95 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | apolipoprotein L1 measurement | 2.93e-03 | 25 | 95 | 2 | EFO_0021854 | |
| Disease | Lymphatic Metastasis | 3.17e-03 | 26 | 95 | 2 | C0024232 | |
| Disease | unipolar depression, depressive symptom measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0003761, EFO_0007006 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QVLDLQDVDENFWTI | 101 | A0A0G2JMD5 | |
| SDWTTELLVVEQLLN | 351 | Q14146 | |
| LQLALQDWDQTVETA | 221 | Q7Z4L5 | |
| LRDNLTLWTSDQQDD | 226 | P61981 | |
| LLDEAQVTLSFQDWL | 351 | Q9NWW7 | |
| IFQDWLGTDQDNLDL | 221 | Q8NHY2 | |
| LLSDAEKLEQVLQWN | 451 | Q9BSJ8 | |
| DFIWVQENIDEIILQ | 3546 | Q99996 | |
| SRENLLQLLTDDEAW | 21 | Q9BQE5 | |
| WDDNLTLDISQLKEQ | 406 | Q9NX77 | |
| WQELCQSDLSLDRQL | 236 | P83436 | |
| LEEWFVEVLQNDLQA | 71 | Q9UJX6 | |
| DNWTLELESSQDIQD | 856 | Q2NKJ3 | |
| ILNELNWTEALENVF | 221 | Q9NY47 | |
| LRDNLTLWTSDQQDE | 226 | Q04917 | |
| SLRQWAQELEENLNE | 326 | Q9BPW4 | |
| DQTDQQEAEWLVLLS | 396 | O95264 | |
| QEQLNWLNEVLTFSD | 216 | Q3LIE5 | |
| SELVVFWQDQENLVL | 51 | P42081 | |
| VLDIWEEENSDNLLT | 646 | Q9UBU7 | |
| AQEIQDESAVLWLDE | 591 | P46940 | |
| ENLVENLLNWTRDSQ | 331 | Q70E73 | |
| NIWLAESVLDILTEQ | 181 | Q68E01 | |
| DSVLNILIQSLDWET | 791 | Q68E01 | |
| KSRELLDNEELQNLW | 86 | Q969Q6 | |
| LQLEDINCINLDWIN | 111 | Q17RR3 | |
| DQEWQELIDELANTV | 306 | Q96JK9 | |
| EETILQDLSGNWVQE | 171 | Q6PRD1 | |
| NLWQLDTEDLTISNV | 596 | Q38SD2 | |
| EHWLQQSEQELENLE | 3936 | Q03001 | |
| EIDSKWQELNQLTID | 4601 | Q03001 | |
| ANLLQAEIEELWATL | 1681 | P13535 | |
| DELDWCLDQLETLQT | 211 | Q08493 | |
| LEELDWCLDQLETLQ | 281 | Q08499 | |
| DLDAWSILIREAQNQ | 31 | Q12996 | |
| LFQDLSQLQETWLAE | 46 | P50549 | |
| WIENLNSVLDDNKTL | 2211 | Q96JB1 | |
| TEWELEQSLQDQALL | 206 | H3BV12 | |
| LQWILDNDISDLGLE | 691 | Q8IYU2 | |
| LTNNLEERIEELEIW | 551 | Q96LU7 | |
| EILWLTQNELNDEVA | 871 | Q9Y239 | |
| VSSLQQEIWEEEDLN | 516 | P48681 | |
| NRTEELLDQLSLSEW | 2121 | Q8NG31 | |
| CNELLSWLEVNQLAE | 576 | P34931 | |
| QDERLWQQETLQELE | 426 | A6NEF3 | |
| LFQDLSQLQEAWLAE | 46 | P41161 | |
| TTIANLQTDNDLLWL | 181 | O94886 | |
| NSLQQSREDWLEAIE | 316 | Q9BXW6 | |
| IQSEQFEDLWLITNE | 601 | Q3SYG4 | |
| LLSWLADTEELIANQ | 5356 | Q9UPN3 | |
| VANAELLEELLAWIQ | 6881 | Q9UPN3 | |
| QEDWNITDFLLLTQN | 271 | Q8TCU5 | |
| EWIESLNSVLDDNRL | 2061 | Q8NCM8 | |
| RQWDQVEQDLADELI | 186 | Q9UJJ9 | |
| IANQIQEDWKSLLTD | 1271 | Q13315 | |
| SLLFTWEELISENNL | 256 | O75794 | |
| LVEELQVDQLWDALL | 16 | P55211 | |
| DVEAWIELAQILEQT | 411 | Q6PD62 | |
| QQLEAWDLDDILQSL | 261 | Q8IYS4 | |
| TQNLLLLLTDNEAWN | 81 | O14791 | |
| EASELDINNAVELEW | 701 | O43303 | |
| FENVTDLQWLILDHN | 86 | P51884 | |
| WVENLNSVLDDNKLL | 2311 | Q14204 | |
| ESAAAEQWVSLQDLL | 436 | Q76NI1 | |
| ENIDEAITLLEQNNW | 21 | Q9UNN5 | |
| TEWELEQSLQDQALL | 206 | I6L899 | |
| TEWELEQSLQDQALL | 206 | A6NCC3 | |
| DADVNNLLLEDLIIW | 746 | Q58EX2 | |
| EQLLANLSAIQEQWE | 221 | Q6PJW8 | |
| EVWLNSLLEESQSSL | 1786 | Q8TE73 | |
| VDAIWIENLNSVLDD | 2341 | Q8TE73 | |
| IAEEQLENSLWIRQE | 441 | Q6ZNG9 | |
| LQEEEIWAVLNQSAE | 16 | Q12923 | |
| ENLFIWEEEDILNLT | 2131 | P56715 | |
| WSELNEDQQDELIRS | 1326 | P42345 | |
| EINILWQELLEEQCL | 526 | P46939 | |
| NDLTQWITEAEELLV | 1986 | P46939 | |
| LTQNALINDELVEWK | 226 | P42224 | |
| VLTDDQVDQALWEEQ | 221 | Q9BSF4 | |
| NDWLEDAQELLQLAG | 5006 | Q8NF91 | |
| AELELWLQQANVAVE | 4246 | Q8WXH0 | |
| SSQDEWQDALNILLE | 266 | P0C2Y1 | |
| LWLDEIQQAVDDANV | 516 | Q13576 | |
| IQWTNLDPEQLLEEL | 211 | Q9Y6C5 | |
| VDDLDTQESVWLVQQ | 36 | Q6ZV89 | |
| TWDILNLADALLEQA | 36 | O75448 | |
| LEWTLQTLLEQLNED | 6 | Q8WX94 | |
| ALLVLWDINTQSNEE | 61 | Q8IZV5 | |
| LQLEDLSLIQAVEWE | 81 | Q13591 | |
| TLDIEWLLTDNEGNQ | 46 | Q9H6B4 | |
| DTELAEELLQWFLQE | 1546 | Q00610 | |
| QQELRDWNLGEDASL | 61 | Q8NAA6 | |
| NVISLLEQEAELWAV | 61 | P52742 | |
| ESLASELLQWIEQTI | 311 | O15020 | |
| SQLQRDELQFIDWEI | 116 | Q14159 | |
| QQLDSWELEDQSAVD | 1126 | A6NE52 | |
| TSQLLLETDWESILQ | 16 | O14964 | |
| LVSDQQQNFLELWSE | 1876 | Q12888 | |
| ETWEVLLLFLLQIND | 161 | Q86X10 | |
| ELADASENLLTENTW | 906 | Q6PKC3 | |
| TLLWDIVQDEDAVNL | 861 | Q70CQ2 | |
| KLLLEWNQLDLANDE | 431 | Q7Z2W7 | |
| LAEDIENEVVQITWN | 696 | Q15029 | |
| VNDLRWDLSAQQIEE | 21 | P52888 | |
| SWRQLALEQLDEQDG | 601 | Q86UV5 | |
| TEWELEQSLQDQALL | 206 | F8WBI6 | |
| LDNDDLQATALDLEW | 36 | Q58DX5 |